Keywords
How to Cite
Abstract
Diabetik nefropatiya qandli diabetning eng og‘ir va prognoz jihatdan noqulay asoratlaridan biri bo‘lib, buyraklarning glomerulyar apparati va tomir tizimining asta-sekin zararlanishi bilan tavsiflanadi. Kasallik uzoq muddatli giperglikemiya fonida rivojlanib, mikroalbuminuriya, proteinuriya va buyrak funksiyasining pasayishi bilan kechadi. Ushbu tezisda diabetik nefropatiyaning rivojlanish mexanizmlari, erta diagnostika mezonlari va zamonaviy profilaktik yondashuvlar tahlil qilinadi. O‘z vaqtida aniqlash va glyukemik hamda arterial bosimni samarali nazorat qilish kasallikning rivojlanishini sekinlashtirishda muhim ahamiyatga ega ekanligi asoslab beriladi.
References
1. Forbes J.M., Cooper M.E. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137–188.
2. Tuttle K.R., Bakris G.L., Bilous R.W. Diabetic kidney disease: a report from an ADA consensus conference. Diabetes Care. 2014;37(10):2864–2883.
3. American Diabetes Association. Microvascular complications and foot care: Standards of Medical Care in Diabetes—2025. Diabetes Care. 2025;48(Suppl. 1):S135–S153.
4. Ritz E., Rychlik I., Locatelli F. End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis. 1999;34(5):795–808.
5. de Boer I.H., Rue T.C., Hall Y.N. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011;305(24):2532–2539.
This work is licensed under a Creative Commons Attribution 4.0 International License.
